Document:

Exhibit 10.55

                                                                     No. CW - __

      THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER THE SECURITIES LAWS OF
ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND
RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT
AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION
THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN
FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY
PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE
STATE SECURITIES LAWS.

                           WARRANT TO PURCHASE SHARES
                               OF COMMON STOCK OF
                                  VAXGEN, INC.
                         (Void after September 21, 2007)

      This certifies that ____________, or its permitted assigns (the "Holder"),
for value received, is entitled to, upon the terms and conditions hereinafter
set forth, subscribe for and purchase from VAXGEN, INC., a Delaware corporation
(the "Company"), having a place of business at 1000 Marina Boulevard, Suite 200,
Brisbane, California 94005, __________ (_____) fully paid and nonassessable
shares (the "Warrant Shares") of the Company's common stock, $0.01 par value per
share ("Common Stock") at the initial exercise price of $16.00 per Warrant Share
(the "Exercise Price") at any time and from time to time, in whole or in part,
up to and including 5:00 p.m. (Pacific time) on September 21, 2007 (the
"Expiration Date") upon surrender to the Company at its principal office (or at
such other location as the Company may advise the Holder in writing) of this
Warrant, with the Form of Subscription attached hereto duly filled in and signed
and upon payment in cash or wire transfer of the aggregate Exercise Price for
the number of shares for which this Warrant is being exercised determined in
accordance with the provisions hereof, or in accordance with the provisions of
Section 1.2 hereof. The Exercise Price and the number of shares purchasable
hereunder are subject to adjustment as provided in Section 3 of this Warrant.

      This Warrant is subject to the following terms and conditions:

            1. EXERCISE; ISSUANCE OF CERTIFICATES; PAYMENT FOR SHARES.

                  1.1 General. This Warrant is exercisable at the option of the
Holder of record hereof, at any time and from time to time and including, up to
the Expiration Date for all or any part of the Warrant Shares (but not for a
fraction of a share) which may be purchased hereunder. The Company agrees that
the Warrant Shares purchased under this Warrant shall be and are deemed to be
issued to the Holder hereof as the record owner of such shares as of the close
of business on the date on which this Warrant shall have been surrendered, the
completed

                                       1.
<PAGE>

and executed Form of Subscription delivered and (except for an exercise effected
pursuant to Section 1.2 hereof) payment made for such shares. Certificates for
the Warrant Shares so purchased, together with any other securities or property
to which the Holder hereof is entitled upon such exercise, shall be delivered to
the Holder hereof by the Company at the Company's expense on or before the later
to occur of (i) the third (3rd) business day following the Company's receipt of
the Form of Subscription by facsimile transmission and (ii) the business day
following the Company's receipt of the original Warrant and Form of Subscription
and, except for an exercise effected pursuant to Section 1.2 hereof, payment for
such shares (the later of (i) and (ii) being referred to herein as the "Delivery
Date"). In case of a purchase of less than all the Warrant Shares which may be
purchased under this Warrant, the Company shall cancel this Warrant and execute
and deliver a new Warrant or Warrants of like tenor for the balance of the
shares purchasable under the Warrant surrendered upon such purchase to the
Holder hereof within a reasonable time; provided, however, that the Holder may
validly exercise this Warrant at any time following such purchase without having
received such new Warrant. Provided that the Holder complies with Section 10.1
of the Warrant Exchange Agreement, dated September 21, 2004 (the "Exchange
Agreement"), the Company shall effect delivery of Warrant Shares to the Holder
by, as long as the Company's transfer agent (the "Transfer Agent") participates
in the Depository Trust Company ("DTC") Fast Automated Securities Transfer
program ("FAST"), crediting the account of the Holder or its nominee at DTC (as
specified in the applicable Exercise Notice) with the number of Warrant Shares
required to be delivered, no later than the close of business on the applicable
Delivery Date. In the event that the Transfer Agent is not a participant in
FAST, or if the Warrant Shares are not otherwise eligible for delivery through
FAST, or if the Holder so specifies in an Exercise Notice or otherwise in
writing, the Company shall effect delivery of Warrant Shares by delivering to
the Holder or its nominee physical certificates representing such Warrant
Shares, no later than the close of business on such Delivery Date. Each stock
certificate so delivered shall be in such denominations of Common Stock as may
be requested by the Holder hereof and shall be registered in the name of such
Holder or in the name of Holder's affiliate and/or subsidiary as may be
requested by the Holder. The Holder shall have the right to pursue actual
damages for the Company's failure to issue and deliver Warrant Shares (without
any restriction legends) on the applicable Delivery Date (including, without
limitation, damages relating to any purchase of Common Stock by the Holder to
make delivery on a sale effected in anticipation of receiving Warrant Shares
upon exercise), and the Holder shall have the right to pursue all other remedies
available to it at law or in equity (including, without limitation, a decree of
specific performance and/or injunctive relief).

                  1.2 Net Issue Exercise. Notwithstanding any provisions herein
to the contrary, if the fair market value of one share of the Company's Common
Stock is greater than the Exercise Price (at the date of calculation as set
forth below), in lieu of exercising this Warrant for cash, the Holder may elect
to receive shares equal to the value (as determined below) of this Warrant (or
the portion thereof being exercised) by surrender of this Warrant at the
principal office of the Company together with the executed Form of Subscription
with notice of such election in which event the Company shall issue to the
Holder a number of Warrant Shares computed using the following formula:

                  X = Y (A-B)
                      -------
                         A

                                       2.
<PAGE>

      Where X = the number of Warrant Shares to be issued to the Holder

                              Y = the number of Warrant Shares purchasable under
                              the Warrant or, if only a portion of the Warrant
                              is being exercised, the portion of the Warrant
                              being exercised (at the date of such calculation)

                              A = the fair market value of one share of the
                              Company's Common Stock (at the date of such
                              calculation)

                              B = Exercise Price (as adjusted to the date of
                              such calculation)

      For purposes of the above calculation, if the Common Stock is traded on
any established stock exchange or traded on the Nasdaq National Market or the
Nasdaq SmallCap Market, then the fair market value of one share of Common Stock
shall be the closing sales price for such stock (or the closing bid, if no sales
were reported) as quoted on such exchange or market (or the exchange or market
with the greatest volume of trading in the Common Stock) on the last market
trading day prior to the day of determination, as reported in The Wall Street
Journal (or such other source as the Company's Board of Directors reasonably
deems reliable). In the event the fair market value of one share of Common Stock
cannot be determined in accordance with the foregoing sentence, such fair market
value shall be the last reported sales price of the Common Stock as reported in
the "pink sheets" by Pink Sheets LLC. In the absence of such markets for the
Common Stock, the fair market value of one share of Common Stock shall be
reasonably determined by the Company's Board of Directors in good faith.

            2. SHARES TO BE FULLY PAID; RESERVATION OF SHARES. The Company
covenants and agrees that all Warrant Shares which may be issued upon the
exercise of the rights represented by this Warrant will, upon issuance, be duly
authorized, validly issued, fully paid and nonassessable and free from all
preemptive rights of any stockholder and free of all taxes, liens and charges
with respect to the issue thereof. The Company further covenants and agrees
that, during the period within which the rights represented by this Warrant may
be exercised, the Company will at all times have authorized and reserved, for
the purpose of issue or transfer upon exercise of the subscription rights
evidenced by this Warrant, a sufficient number of shares of authorized but
unissued Common Stock, or other securities and property, when and as required to
provide for the exercise of the rights represented by this Warrant. The Company
will take all such action as may be necessary to assure that such Warrant Shares
may be issued as provided herein without violation of any applicable law or
regulation, or of any requirements of any securities exchange or market upon
which the Common Stock may be listed or traded; provided, however, that the
Company shall not be required to effect a registration under federal or state
securities laws solely because of such exercise. The Company will not take any
action which would result in any adjustment of the Exercise Price (as set forth
in Section 3 hereof) if the total number of shares of Common Stock issuable
after such action upon exercise of all outstanding warrants, together with all
shares of Common Stock then outstanding and all shares of Common Stock then
issuable upon exercise of all options and upon the conversion of all convertible

                                       3.
<PAGE>

securities then outstanding, would exceed the total number of shares of Common
Stock then authorized by the Company's Certificate of Incorporation.

            3. ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF SHARES. The Exercise
Price and the number of shares purchasable upon the exercise of this Warrant
shall be subject to adjustment from time to time upon the occurrence of certain
events described in this Section 3. Upon each adjustment of the Exercise Price,
the Holder of this Warrant shall thereafter be entitled to purchase, at the
Exercise Price resulting from such adjustment, the number of shares obtained by
multiplying the Exercise Price in effect immediately prior to such adjustment by
the number of shares purchasable pursuant hereto immediately prior to such
adjustment, and dividing the product thereof by the Exercise Price resulting
from such adjustment.

                  3.1 Subdivision or Combination of Stock. In case the Company
shall at any time subdivide its outstanding shares of Common Stock into a
greater number of shares, the Exercise Price in effect immediately prior to such
subdivision shall be proportionately reduced, and conversely, in case the
outstanding shares of Common Stock of the Company shall be combined into a
smaller number of shares, the Exercise Price in effect immediately prior to such
combination shall be proportionately increased.

                  3.2 Dividends in Common Stock, Other Stock, Property,
Reclassification. If at any time or from time to time the holders of Common
Stock (or any shares of stock or other securities at the time receivable upon
the exercise of this Warrant) shall have received or become entitled to receive,
without payment therefor,

                        (a) Common Stock or any shares of stock or other
securities which are at any time directly or indirectly convertible into or
exchangeable for Common Stock, or any rights or options to subscribe for,
purchase or otherwise acquire any of the foregoing by way of dividend or other
distribution,

                        (b) any cash paid or payable otherwise than as a cash
dividend, or

                        (c) Common Stock or additional stock or other securities
or property (including cash) by way of spinoff, split-up, reclassification,
combination of shares or similar corporate rearrangement, (other than shares of
Common Stock issued as a stock split or adjustments in respect of which shall be
covered by the terms of Section 3.1 above),

then and in each such case, the Holder hereof shall, upon the exercise of this
Warrant, be entitled to receive, in addition to the number of Warrant Shares
receivable thereupon, and without payment of any additional consideration
therefor, the amount of stock and other securities and property (including cash
in the cases referred to in clauses (b) and (c) above) which such Holder would
hold on the date of such exercise had such holder been the holder of record of
such Common Stock as of the date on which holders of Common Stock received or
became entitled to receive such shares or all other additional stock and other
securities and property.

                  3.3 Reorganization, Reclassification, Consolidation, Merger or
Sale. If any recapitalization, reclassification or reorganization of the capital
stock of the Company, or any consolidation or merger of the

                                       4.
<PAGE>

Company with another corporation, or the sale of all or substantially all of its
assets or other transaction shall be effected in such a way that holders of
Common Stock shall be entitled to receive stock, securities, or other assets or
property (an "Organic Change"), then, as a condition of such Organic Change,
lawful and adequate provisions shall be made by the Company whereby the Holder
hereof shall thereafter have the right to purchase and receive (in lieu of the
shares of the Common Stock of the Company immediately theretofore purchasable
and receivable upon the exercise of the rights represented hereby) such shares
of stock, securities or other assets or property as may be issued or payable
with respect to or in exchange for a number of outstanding shares of such Common
Stock equal to the number of shares of such stock immediately theretofore
purchasable and receivable upon the exercise of the rights represented hereby.
In the event of any Organic Change, appropriate provision shall be made by the
Company with respect to the rights and interests of the Holder of this Warrant
such that the provisions hereof (including, without limitation, provisions for
adjustments of the Exercise Price and of the number of shares purchasable and
receivable upon the exercise of this Warrant) shall thereafter be applicable, in
relation to any shares of stock, securities or assets thereafter deliverable
upon the exercise hereof. The Company will not effect any such consolidation,
merger or sale unless, prior to the consummation thereof, the successor
corporation (if other than the Company) resulting from such consolidation or
merger or the corporation purchasing such assets shall assume by written
instrument the obligation to deliver to such Holder such shares of stock,
securities or assets as, in accordance with the foregoing provisions, such
Holder may be entitled to purchase.

                  3.4 Certain Events. If any change in the outstanding Common
Stock of the Company or any other event occurs as to which the other provisions
of this Section 3 are not strictly applicable or if strictly applicable would
not fairly protect the purchase rights of the Holder of the Warrant in
accordance with such provisions, then the Board of Directors of the Company
shall make an adjustment in the number and class of shares available under the
Warrant, the Exercise Price or the application of such provisions, so as to
protect such purchase rights as aforesaid. The adjustment shall be such as will
give the Holder of the Warrant upon exercise for the same aggregate Exercise
Price the total number, class and kind of shares as such Holder would have owned
had the Warrant been exercised prior to the event and had such Holder continued
to hold such shares until after the event requiring adjustment.

                  3.5 Notices of Change.

                        (a) Immediately upon any adjustment in the number or
class of shares subject to this Warrant and of the Exercise Price, the Company
shall give written notice thereof to the Holder, setting forth in reasonable
detail and certifying the calculation of such adjustment.

                        (b) The Company shall give written notice to the Holder
at least ten (10) calendar days prior to the date on which the Company closes
its books or takes a record for determining rights to receive any dividends or
distributions or any right to subscribe for, purchase or otherwise acquire any
shares of stock of any class or any other securities or property, or to receive
any other right.

                                       5.
<PAGE>

                        (c) The Company shall give written notice to the Holder
at least ten (10) calendar days prior to the date on which an Organic Change
shall take place, including in such notice the date as of which the Organic
Change is expected to become effective and the date as of which it is expected
that holders of Common Stock of record shall be entitled to exchange their
Common Stock for securities or other property, if any, deliverable upon such
Organic Change.

                        (d) The Company shall initiate the delivery of written
notice to the Holder of any voluntary or involuntary dissolution, liquidation or
winding-up of the Company (the "Dissolution") on the date such Dissolution is
publicly announced, including in such notice the date as of which the
Dissolution is expected to become effective and the date as of which it is
expected that holders of Common Stock of record shall be entitled to exchange
their Common Stock for securities or other property, if any.

            4. LISTING. The Company shall file any forms and do any acts as
shall be required from time to time to secure the listing or quotation of the
Warrant Shares with each national securities exchange or automated quotation
system, if any, upon which shares of such securities are then listed or traded
and shall use its commercially reasonable efforts to maintain, so long as any
other shares of such securities shall be so listed or traded, such listing or
quotation of all securities issued or issuable upon the exercise of this
Warrant.

            5. ISSUE TAX. The issuance of certificates for Warrant Shares upon
the exercise of the Warrant shall be made without charge to the Holder of the
Warrant for any issue tax (other than any applicable income taxes) in respect
thereof; provided, however, that the Company shall not be required to pay any
tax which may be payable in respect of any transfer involved in the issuance and
delivery of any certificate in a name other than that of the then Holder of the
Warrant being exercised.

            6. CLOSING OF BOOKS. The Company will at no time close its transfer
books against the transfer of any warrant or of any shares of Common Stock
issued or issuable upon the exercise of any warrant in any manner which
interferes with the timely exercise of this Warrant.

            7. NO VOTING OR DIVIDEND RIGHTS; LIMITATION OF LIABILITY. Nothing
contained in this Warrant shall be construed as conferring upon the Holder
hereof the right to vote or to consent or to receive notice as a stockholder of
the Company or any other matters or any rights whatsoever as a stockholder of
the Company. Except as expressly set forth in Section 3 herein, no dividends or
interest shall be payable or accrued in respect of this Warrant or the interest
represented hereby or the shares purchasable hereunder until, and only to the
extent that, this Warrant shall have been exercised. No provisions hereof, in
the absence of affirmative action by the Holder to purchase Warrant Shares, and
no mere enumeration herein of the rights or privileges of the Holder hereof,
shall give rise to any liability of such Holder for the Exercise Price or as a
stockholder of the Company, whether such liability is asserted by the Company or
by its creditors.

            8. REPRESENTATIONS OF HOLDER. Holder further represents that it
understands that neither this Warrant nor the Warrant Shares issuable upon the
exercise thereof have been

                                       6.
<PAGE>

registered under the Act, and are being offered pursuant to an exemption from
registration contained in the Act based in part upon Holder's representations
contained in this Section 8. Holder represents that by reason of its own, or of
its management's, knowledge and experience in financial and business matters,
Holder is capable of evaluating the merits and risks of its investment in the
Company and has the capacity to protect its own interests in connection with the
issuance of this Warrant and the Warrant Shares issuable upon the exercise
thereof, and is able to bear risk, including a complete loss, of the investment.
Holder represents that it is an "accredited investor" within the meaning set
forth in Regulation D under the Act. Holder represents that it is acquiring such
securities for its own account for investment only, and not with a view towards
their distribution, except pursuant to sales that are registered under the Act
or are exempt from the registration requirements of the Act; provided, however,
that, in making such representation, the Holder does not agree to hold such
securities for any minimum or specific term and reserves the right to sell,
transfer or otherwise dispose of such securities at any time in accordance with
the provisions hereof and with Federal and state securities laws applicable to
such sale, transfer or disposition.

            9. TRANSFERABILITY. Subject to compliance with any applicable
securities laws, this Warrant may be transferred, provided that Holder provides
prior written notice of such transfer to the Company, such transferee agrees to
be bound by the obligations hereunder and such transferee agrees to execute
certain documentation requested by the Company including an investment letter.
Upon the transfer of the Warrant, the Company may treat such transferee as the
absolute owner hereof for any purpose and as the person entitled to exercise the
rights represented by this Warrant.

            10. RIGHTS AND OBLIGATIONS SURVIVE EXERCISE OF WARRANT. The rights
and obligations of the Company, of the Holder of this Warrant and of the holder
of Warrant Shares issued upon exercise of this Warrant, shall survive the
exercise of this Warrant.

            11. MODIFICATION AND WAIVER. This Warrant and any provision hereof
may be changed, waived, discharged or terminated only by an instrument in
writing signed by the party against which enforcement of the same is sought.

            12. NOTICES. Any notice, request or other document required or
permitted to be given or delivered to the Holder hereof or the Company shall be
in writing, shall refer specifically to this Warrant and shall be delivered and
deemed received in accordance with Section 11.1 of the Exchange Agreement.

            13. BINDING EFFECT ON SUCCESSORS. This Warrant shall be binding upon
any corporation succeeding the Company by merger, consolidation or acquisition
of all or substantially all of the Company's assets. All of the covenants and
agreements of the Company shall inure to the benefit of the successors and
permitted assigns of the Holder hereof.

            14. DESCRIPTIVE HEADINGS AND GOVERNING LAW. The description headings
of the several sections and paragraphs of this Warrant are inserted for
convenience only and do not constitute a part of this Warrant. This Warrant
shall be construed and enforced in accordance with, and the rights of the
parties shall be governed by, the laws of the State of California.

                                       7.
<PAGE>

            15. LOST WARRANTS. The Company represents and warrants to the Holder
hereof that upon receipt of evidence reasonably satisfactory to the Company of
the loss, theft, destruction, or mutilation of this Warrant and, in the case of
any such loss, theft or destruction, upon receipt of an indemnity reasonably
satisfactory to the Company, or in the case of any such mutilation upon
surrender and cancellation of such Warrant, the Company, at its expense, will
make and deliver a new Warrant, of like tenor, in lieu of the lost, stolen,
destroyed or mutilated Warrant.

            16. FRACTIONAL SHARES. No fractional shares shall be issued upon
exercise of this Warrant. The Company shall, in lieu of issuing any fractional
share, pay the Holder entitled to such fraction a sum in cash equal to such
fraction multiplied by the then effective Exercise Price.

                      [THIS SPACE INTENTIONALLY LEFT BLANK]

                                       8.
<PAGE>

      IN WITNESS WHEREOF, the Company has caused this Warrant to be duly
executed by its officers, thereunto duly authorized this ___ day of September,
2004.

                                             VAXGEN, INC.

                                             By:
                                                 -----------------------------
                                                 Lance K. Gordon
                                                 Chief Executive Officer

<PAGE>
                                SUBSCRIPTION FORM

                                             Date: _________________, 200_

VaxGen, Inc.
1000 Marina Boulevard, Suite 200
Brisbane, California 94005
Attn: Chief Financial Officer

Ladies and Gentlemen:

|_|   The undersigned hereby elects to exercise the warrant issued to it by
      VaxGen, Inc. (the "Company") and dated September ____, 2004 Warrant No.
      CW-___ (the "Warrant") and to purchase thereunder
      __________________________________ shares of the Common Stock of the
      Company (the "Shares") at a purchase price of $16.00 per Share or an
      aggregate purchase price of ________________ Dollars ($__________) (the
      "Purchase Price"). Pursuant to the terms of the Warrant the undersigned
      has delivered the Purchase Price herewith in full in cash or wire
      transfer.

|_|   The undersigned hereby elects to convert ______________________ percent
      (___%) of the value of the Warrant pursuant to the provisions of Section
      1.2 of the Warrant.

                                         Very truly yours,

                                         ---------------------------------------
                                             Print Entity Name, if applicable

                                         By:
                                            ------------------------------------

                                         Print Name:
                                                    ----------------------------

                                         Title:
                                               ---------------------------------Exhibit 10.12

                              AMENDED AND RESTATED
                          INVESTOR RELATIONS AGREEMENT

         This Amended and Restated Investor Relations Agreement is made as of
this __ day of August, 2004, by and between Health Systems Solutions, Inc. (the
"Company"), a corporation duly organized and existing under the laws of the
State of Nevada, having its principal place of business at 405 N. Reo Street,
Suite 300, Tampa, Florida 33609 and American Capital Ventures, Inc. (the
"Consultant"), a corporation duly organized and existing under the laws of the
State of Florida, with offices at 2875 N.E. 191st Street, Suite 512, Aventura,
Florida 33180, and amends and restates in its entirety the Investor Relations
Agreement dated as of July 1, 2004.

         WHEREAS, the Company is a public company engaged in developing software
solutions for companies in the healthcare industry;

         WHEREAS, the Consultant is experienced in providing investor relations
advice to publicly-traded companies; and

         WHEREAS, the Company wishes to retain the services of the Consultant on
a non-exclusive basis on the terms and conditions set forth herein.

         NOW THEREFORE, in consideration of the mutual covenants contained
herein and other valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties agree that the foregoing preliminary
statements are true and further agree as follows:

         1. The Company hereby retains the services of the Consultant for a
period of eighteen months (the "Initial Term"), which shall automatically be
renewed for successive one-year terms (the "Successive Terms"). Following the
expiration of the Initial Term, either party may terminate any Successive Term
upon fifteen (15) days written notice. The cancellation and termination of this
Agreement shall not impact the rights of the parties as set forth in any other
agreements the Consultant and the Company have executed or may execute in the
future, said agreements shall remain in full force and effect.

         2. In exchange for the Consulting Services (as that term is defined
below) rendered during the Initial Term, the Consultant shall receive a fee of
$12,000 per month payable on the 1st day of every month commencing on July 1,
2004. The Consultant shall also be reimbursed actual reasonable travel and other
out of pocket expenses which will be billed in arrears and are due and payable
within thirty (30) days of the Company's receipt of the subject bill(s). The
Consultant shall also receive a fee of 225,000 shares of common stock of the
Company. Certificates for such shares will be delivered to Consultant as
follows: 50,000 shares within fourteen days of the date hereof, 10,000 per month
for the months of August 2004 through December 2005 and 5,000 shares on January
2006. In the event that this Agreement is terminated prior to the end of the
initial Term, the Company shall be under no obligation to deliver any
certificates not delivered to the Consultant prior to the date of notice of
termination. The Company and the Consultant agree that the value of the 225,000
shares as of the date of this Agreement is an aggregate of $2,250.00.

         3. The Company agrees to include the underlying common stock issued
pursuant to this Agreement in connection with a Registration Statement on Form
SB-2 it filed on or about July 9, 2004 (the "SB-2 Registration Statement"). The
Company shall bear all fees and expenses incurred by the Company in connection
with the preparation and filing of such registration statement(s). The Company
will use commercially reasonable efforts to keep such registration statement
current for nine (9) months.

         4. The Consultant shall utilize its best efforts to provide the
following services to the Company: (a) assist the Company in making
presentations to interested brokerage firms, hedge funds and institutional
investors that buy and follow health care related and technology stocks, (b)
assist and facilitate the Company's initial listing application to trade its
shares of common stock on the American Stock Exchange ("AMEX") or Nasdaq
National Market System or SmallCap Market ("Nasdaq"), and introduce the Company
to one or more qualified specialists on the AMEX trading floor or market markers
in connection with Nasdaq trading, (c) coordinate meetings with analysts to

<PAGE>

cover the Company's stock and help disseminate the Company's investment profile
to these analysts, as well as brokerage firms, hedge fund managers and
institutional investors through a variety of electronic and manual sources, (d)
a review of public relations and marketing materials that have been, or may be,
distributed to the U.S. financial community and make appropriate suggestions as
to how these materials can or should be changed, (e) advise the Company on
symposium presentations, as well as investor conferences, (f) assist the Company
through Consultant's existing and future relationships in areas relating to
future financings, mergers, acquisitions and potential buyouts; the parties
agree that any such transaction will be subject to a separate fee agreement
between the parties and limited to transactions generated by the Consultant,
excluding any transactions generated by other parties for which the Consultant
will not be entitled to compensation, (g) at the appropriate time, have the
Company deliver presentations to the staff of the Consultant, as well as the
offices of other brokerage firms with whom the Consultant maintains a
relationship, and (h) through media contacts, attempt to initiate interviews for
the Company on news shows such as CNBC, CNN and Bloomberg. The services referred
to in this paragraph shall be known as the "Consulting Services." In connection
with the provision of the Consulting Services, the Consultant shall make
available to the Company the personal services of Howard Gostfrand.

         5. The Consultant shall be an independent contractor and shall have no
right or authority to assume or create any obligations or responsibility,
express or implied, on behalf of or in the name of the Company, unless
specifically authorized in writing by the Company. No provision of this
Agreement shall be construed to preclude the Consultant, or any officer,
director, agent, assistant, affiliate or employee of the Consultant from
engaging in any activity whatsoever, including, without limitation receiving
compensation for managing investments, or acting as an advisor, broker or dealer
to, or participate in, any corporation, partnership, trust or other business
entity or from receiving compensation or profit therefore. The Consultant shall
have no obligation to present any business combination to the Company and shall
incur no liability for its failure to do so.

         6. The Consultant (including any person or entity acting for or on
behalf of the Consultant) shall not be liable for any mistakes of fact, errors
of judgment, for losses sustained by the Company or any subsidiary or for any
acts or omissions of any kind, unless caused by the gross negligence or
intentional misconduct of the Consultant or any person or entity acting for or
on behalf of the Consultant.

         7. The Company may terminate Consultant at any time upon 30 days' prior
written notice. In the event of such termination, the Company shall have no
further obligation to make any payments to, or bestow any benefits on,
Consultant from and after the date of termination, other than payments or
benefits accrued by Consultant through the date of termination. Notwithstanding
the foregoing, the Company may terminate this Agreement immediately in the event
that at any time during the term hereof Howard Gostfrand is no longer a
full-time employee of the Consultant; it being understood that the foregoing
shall not prevent Howard Gostfrand from having other business interests.

         8. The Company and the Consultant (along with their respective
affiliates, successors and assigns, officers, directors, partners, members,
managers, stockholders, employees and agents thereof), as the case may be, shall
indemnify and hold harmless the other (the party seeking indemnification being
referred to as the "Indemnified Party") from and against any and all claims,
losses, liabilities, judgment, award, fine, penalty, sanction, cost and damages,
including, without limitation, amounts paid in settlement, reasonable costs of
investigation and reasonable fees and disbursements of counsel, accountants and
other advisors (collectively, "Damages"), arising out of or resulting from the
inaccuracy of any representation or warranty, or the breach of any covenant or
agreement, contained herein or in any instrument or certificate delivered
pursuant hereto, by the party against whom indemnification is sought (the
"Indemnifying Party"). The Indemnified Party shall promptly notify the
Indemnifying Party in writing of any claim for indemnification, specifying in
reasonable detail the factual and legal bases of such claim, the facts
pertaining thereto and, if known, the amount, or an estimate of the amount, of
the Damages arising therefrom.

                  Upon the receipt of a claim notice involving the assertion of
liability, or the commencement of any action, suit or proceeding, by a person
other than an Indemnifying Party or an Indemnified Party (such person, a "Third
Party" and such claim, a "Third Party Claim"), the Indemnifying Party shall have
the option to assume the defense and control of such Third Party Claim. Failure
by the Indemnifying Party to notify the Indemnified Party of its election to
defend any such claim, action or proceeding within a reasonable time, but in no
event more than fifteen days after notice thereof shall have been given to the
Indemnifying Party, shall be deemed a waiver by the Indemnifying Party of its
right to defend such claim, action or proceeding; provided, however, that the
Indemnifying Party shall not be deemed to have waived its right to contest and
defend against any claim of the Indemnified Party for indemnification hereunder
based upon or arising out of such claim, action or proceeding.

                                       2
<PAGE>

                  If the Indemnifying Party assumes the defense of any such
Third Party Claim, the obligation of the Indemnifying Party as to such Third
Party Claim shall be limited to taking all steps necessary in the defense or
settlement thereof; provided, however, that the Indemnifying Party shall select
counsel, contractors and consultants of recognized standing and competence after
consultation with the Indemnified Parties and shall at all times diligently and
promptly pursue the resolution of such Third Party Claim. If the Indemnifying
Party is held to be liable for indemnification hereunder, the Indemnifying Party
will pay all Damages caused by or arising out of any settlement approved by the
Indemnifying Party or any judgment or award rendered in connection with such
Third Party Claim. The Indemnified Party may participate, at its expense, in the
defense of such Third Party Claim provided that the Indemnifying Party shall
direct and control the defense of such Third Party Claim. The Indemnified Party
agrees to cooperate and make available to the Indemnified Party all books and
records and such officers, employees and agents as are reasonably necessary and
useful in connection with the defense. The Indemnifying Party shall not, in the
defense of such Third Party Claim, consent to the entry of any judgment or
award, or enter into any settlement, except in either event with the prior
consent of the Indemnified Party, which does not include as an unconditional
term thereof the giving by the claimant or the plaintiff to the Indemnified
Party of a release from all liability in respect of such Third Party Claim.
Notwithstanding the foregoing, the Indemnifying Party shall not enter into any
non-cash settlement without the prior consent of the Indemnified Party.

                  If the Indemnifying Party does not assume the defense of any
such Third Party Claim, the Indemnified Party may defend against such Third
Party Claim in such manner as it may deem appropriate. The Indemnifying Party
agrees to cooperate and make available to the Indemnified Party all books and
records and such officers, employees and agents as are reasonably necessary and
useful in connection with the defense. If the Indemnifying Party, within ten
days after notice shall have been given to it by the Indemnified Party of the
latter's intention to effect a settlement of any such Third Party Claim, which
notice shall describe with particularity the terms of any such proposed
settlement, shall not deposit with an escrow mutually satisfactory to the
Indemnified Party and the Indemnifying Party a sum equivalent to the total
amount demanded in such Third Party Claim or deliver to the Indemnified Party a
surety bond or an irrevocable letter of credit for such sum in form and
substance reasonably satisfactory to the Indemnified Party, then the Indemnified
Party may settle such Third Party Claim on the terms detailed in its notice to
the Indemnifying Party, and the Indemnifying Party shall be deemed to have
agreed to the terms of such settlement and shall not thereafter in any
proceeding by the Indemnified Party for indemnification question the propriety
of such settlement. Notwithstanding the foregoing, the Indemnified Party shall
not, in the defense of such Third Party Claim, consent to the entry of any
judgment or award, or enter into any settlement, except in either event with the
prior consent of the Indemnifying Party, which does not include as an
unconditional term thereof the giving by the claimant or the plaintiff to the
Indemnifying Party of a release from all liability in respect of such Third
Party Claim. In defending any Third Party Claim, the Indemnified Party shall
select counsel, contractors and consultants of recognized standing and
competence and shall at all times diligently and promptly pursue the resolution
of such Third Party Claim.

                  The Indemnifying Parties shall also be liable for the
reasonable fees and expenses of counsel incurred by each Indemnified Party in
defending any Third Party Claim if (i) such Third Party Claim, if successful, is
likely to result in a judgment, decree or order of injunction or other equitable
relief or relief for other than money Damages against such Indemnified Party; or
(ii) the Indemnified Party reasonably concludes that the Indemnifying Parties
and such Indemnified Party have conflicting interests or different defenses
available with respect to such Third Party Claim.

                  In the event any claim notice that does not involve a Third
Party Claim, if the Indemnifying Party does not notify the Indemnified Party
within thirty (30) calendar days following its receipt of such Claim Notice that
the Indemnifying Party disputes the matters set forth in the Claim Notice, or
the amount thereof, the claim specified by the Indemnified Party in such Claim
Notice shall be conclusively deemed a liability of the Indemnifying Party
hereunder, and the Indemnifying Party shall pay or cause to be paid the amount
of such liability to the Indemnified Party on demand or, in the case of any
notice in which the amount of the claim (or any portion of the claim) is
estimated, on such later date when the amount of such claim (or such portion of
such claim) becomes finally determined. If the Indemnifying Party has timely
disputed the liability of the Indemnifying Parties with respect to such claim as
provided above, or the amount thereof, the Indemnifying Party and the
Indemnified Party shall resolve such dispute in accordance with Section 15,
below.

         9. This Agreement shall be binding upon the Company and the Consultant
and their respective successors and assigns. This Agreement may not be assigned
by the Consultant, without the Company's consent.

                                       3

<PAGE>

         10. Consultant acknowledges that as a result of its engagement with the
Company, Consultant will acquire knowledge of and may make use of certain
information which is of a special and unique nature which may include, but is
not limited to, such information concerning the Company's financial condition,
prospects, technology, customers, suppliers, sources of leads and methods of
doing business and any other information disclosed to Consultant or known by
Consultant as a consequence of or through its engagement by the Company prior to
or after the date hereof, and not generally known, about the Company
(collectively, the "Confidential Information"). Consultant agrees to keep in
strict secrecy and confidence any and all Confidential Information of which
Consultant knows of or to which Consultant has access that has not been publicly
disclosed and is not a matter of common knowledge with respect to the Company.
Consultant will not, without the Company's prior written consent, disclose any
such Confidential Information to any third person or entity. The terms and
conditions of this Agreement shall be deemed Confidential Information.

         11. The relationship between Company and Consultant shall be solely as
independent contractor and neither party shall be deemed a joint venturer,
partner agent, representative or employee of the other. Nothing contained in
this Agreement shall constitute any form of employment agreement between
Consultant and the Company. Consultant further acknowledges and agrees that
Consultant is an independent contractor and not an agent, representative or
employee of Company and that Consultant is not entitled to any benefits,
insurance, salary, commission, incentives, or other compensation, other than as
expressly set forth herein. Consultant is solely responsible for securing, at
its sole cost, Workers' Compensation insurance, disability benefits insurance
and any other insurance as may be required by law.

         12. If any provision or provisions of this Agreement shall be held to
be invalid, illegal or unenforceable for any reason whatsoever; (i) the
validity, legality and enforceability of the remaining provisions of this
Agreement (including, without limitation, each portion of any section of this
Agreement containing any such provision held to be invalid, illegal or
unenforceable) shall not in any way be affected or impaired thereby; and (ii) to
the fullest extent possible, the provisions of this Agreement (including,
without limitation, each portion of any section of this Agreement containing any
such provision held to be invalid, illegal or unenforceable) shall be construed
so as to give effect to the intent manifested by the provision held, invalid
illegal or unenforceable.

         13. No supplement, modification or amendment of this Agreement shall be
binding unless executed in writing by both parties hereto. No waiver of any
other provisions hereof (whether or not similar) shall be binding unless
executed in writing by both parties hereto nor shall such waiver constitute a
continuing waiver.

         14. This Agreement may be executed in one or more counterparts, each of
which shall for all purposes be deemed to be an original but all of which shall
constitute one and the same Agreement.

         15. This Agreement shall be governed by the laws of the State of
Florida. All claims or disputes relating in any way to the performance,
interpretation, validity, or breach of this Agreement shall be referred to final
and binding arbitration, before a panel of three arbitrators, under the
commercial arbitration rules of the American Arbitration Association (the "AAA")
in Miami-Dade County, Florida. Each party shall appoint an arbitrator and the
third arbitrator shall be selected by the two appointed arbitrators within
twenty days, following the receipt of written notice of arbitration, as
prescribed by the AAA. In the event that both appointed arbitrators are unable
to select the third arbitrator within a period twenty days, the AAA shall be
permitted to submit an appointment. The arbitrators' award shall be in writing,
made by a majority thereof, and include findings of fact and conclusions of law.
Judgment upon the award rendered by the arbitrators shall be final, binding and
conclusive upon the parties and their respective administrators, executors,
legal representatives, heirs, successors and permitted assigns. The expenses of
the arbitration shall be borne by the losing party or in such proportion as the
arbitrators shall decide. The successful party shall recover as expenses and
costs all reasonable attorney's fees incurred by it in connection with the
arbitration proceeding or any appeals from the proceeding. All information,
documents and other communications delivered, made or exchanged between the
parties and their representatives in connection with any arbitration proceeding
shall be deemed Confidential Information and subject to the provisions of
Section 10, above

         16. This Agreement contains the entire agreement between the parties
with respect to the services to be provided to the Company by the Consultant and
supersedes any and all prior understandings, agreement or correspondence between
the parties, including without limitation the version of this agreement executed
by the parties on or about July __, 2004.

                                       4
<PAGE>

         IN WITNESS WHEREOF, the Company and the Consultant have caused this
Agreement to be signed by their duly authorized representatives as of the day
and year first above written.

                                                 HEALTH SYSTEMS SOLUTIONS INC.

                                                 By:/s/ Brian Milvain
                                                    ----------------------------
                                                 Name:  Brian M. Milvain
                                                 Title: Chief Executive Officer

                                                 AMERICAN CAPITAL VENTURES, INC.

                                                 By:/s/ Howard Gostfrand
                                                    ----------------------------
                                                 Name:  Howard Gostfrand
                                                 Title: President

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}]]